Top compounds associated with response to SLC6A13


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.074 0.03
mRNA TAE684 GDSC1000 pan-cancer AAC -0.12 0.03
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.078 0.03
mRNA etoposide GDSC1000 pan-cancer AAC -0.079 0.03
mRNA WAY-362450 CTRPv2 pan-cancer AAC 0.079 0.03
mRNA Zibotentan GDSC1000 pan-cancer AAC -0.074 0.03
mRNA OSI-906 CTRPv2 pan-cancer AAC 0.073 0.03
mRNA PF-4708671 GDSC1000 pan-cancer AAC 0.077 0.03
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.059 0.04
mRNA LY-2183240 CTRPv2 pan-cancer AAC -0.068 0.04
Download CSV